Antimicrobials in the era of AMR Virtual event November 19th 2021 at 14:00 EDT
During World Antimicrobial Awareness Week (Nov. 18-24 2021), the 不良研究所 AMR Centre and Innovation + Partnership office are hosting the inaugural 不良研究所 AMR Innovation Summit, a virtual event aimed at discussing antimicrobial R&D and building collaborations and partnerships between 不良研究所 scientists and non-academic stakeholders.
Program
- 14:00-14:30 Keynote speaker Erin Duffy, PhD | 鈥淏uilding a Portfolio of Products to Address AMR鈥听听 (public event)
- 14:30-15:00 Panel discussion (public event)
- 15:00-16:00 Industry-Academic networking event (private event)
听
Keynote speaker Erin Duffy, PhD, Chief of Research & Development, CARB-X
CARB-X is a global non-profit partnership dedicated to accelerating antibacterial research to tackle the global rising threat of drug-resistant bacteria. CARB-X funds the world鈥檚 largest early development pipeline of new antibiotics, vaccines, rapid diagnostics, and other products to prevent, diagnose and treat life-threatening bacterial infections. Prior to CARB-X, she worked at Melinta Therapeutics (fka Rib-X Pharmaceuticals) where she became EVP, Chief Scientific Officer. Erin began her career in the Central Research Labs of Pfizer as a computational chemist and structural biologist.
听
Panel Discussion Challenges and Opportunities for Antimicrobial Research and Development in the Era of AMR
With experts from industry and academia.
Confirmed panelists:
鈥 Erin Duffy, PhD, Chief of Research & Development, CARB-X
鈥 Joseph Mancini, PhD, Head of Pharmacology and Biologics, Senior Director at adMare BioInnovations
鈥 Nicolas Moitessier, PhD, Professor in Chemistry (不良研究所), co-founder of Molecular Forecaster
鈥 Martin Schmeing, PhD, Professor in Biochemistry (不良研究所), Director of Centre for Structural Biology
鈥 Makeda Semret, MSc, MD, FRCPC, Associate Professor of Medicine, Infectious Diseases and Medical Microbiology (不良研究所); Lead, Antimicrobial Stewardship Program (MUHC)
鈥 Christopher Tan, PhD, Director, BD&L, Infectious Diseases & Vaccines, Merck & Co., Inc.
听
听
If you have any questions, please contact us at amrcentre [at] mcgill.ca
听